Moderna reports 'positive' results from early data on coronavirus vaccine

The biotech company Moderna on Monday reported “positive” data on its potential coronavirus vaccine from an early clinical trial, raising hopes about the effort.

The company said early data from a phase one clinical trial showed that people given the potential vaccine generated an immune response similar to that in people who had recovered from the disease.

The levels of neutralizing antibodies were “at or above” the levels seen in blood samples from people who have recovered from the coronavirus, Moderna said in a statement.

Still, that early result is...